Advances in Hematological Malignancies

Recent decades have witnessed remarkable strides in the area of hematological malignancies. Novel therapies such as targeted agents, immunotherapies, and gene editing are transforming the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative strategies, offering promise for more effective treatm

read more